Business Update MaaT Pharma Announces Initiation of New Collection and Manufacturing Campaign for its Microbiome Biotherapeutic Product Portfolio New collection campaign to support future clinical development of microbiome biotherapeutic product portfolio and to…MaaT PharmaAugust 20, 2020
Business Update MaaT Pharma Appoints Claude Bertrand, Servier’s Executive Vice President of R&D, as Independent Board Member and Welcomes New Chief Medical Officer John Weinberg Lyon, France, July 16, 2020 – MaaT Pharma announced today the appointment of Claude Bertrand,…MaaT PharmaJuly 16, 2020
Press Releases MaaT Pharma Appoints Savita Bernal as Chief Business Officer Lyon, France, May 28, 2020 – MaaT Pharma announced today that Savita Bernal, PhD, has…MaaT PharmaMay 28, 2020
Press Releases MaaT Pharma Announces Formation of Its GvHD-focused Scientific Advisory Board to Support Development of Microbiome Restoration Therapeutics in Hemato-oncological Indications Lyon, France, May 12, 2020 – MaaT Pharma announced today the appointment of leading international…nboutaouiMay 12, 2020
Business Update PR FDA Safety Alert In response to the recent “FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation…nboutaouiMarch 13, 2020
Business Update MaaT Pharma – Information COVID-19 March 13th, 2020 MaaT Pharma – Information COVID-19 In the context of the COVID-19…nboutaouiMarch 13, 2020
Business Update MaaT Pharma – Information COVID-19 Le 13 mars 2020 MaaT Pharma - Information covid 19 Dans le cadre…nboutaouiMarch 13, 2020
Press Releases MaaT Pharma Annonce 18 millions d’euros de Financement Série B pour l’Expansion de son Développement Clinique de Médicaments Biologiques « Microbiote » Lyon, le 5 février 2020 - MaaT Pharma annonce aujourd'hui une levée de fonds de…nboutaouiFebruary 4, 2020
Press Releases MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…nboutaouiJanuary 31, 2020